LOU SILVERMAN
CIK 1249935 · Chief Executive Officer · last filed 2026-06-03
LOU SILVERMAN is a Chief Executive Officer who has filed 38 SEC Form 4 insider transactions across 4 companies since 2009. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $802.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$802.8K
4
38
-$6.86M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | 36,564 | $3.20 | $117.0K | $0 | 3 | 2025-07-03 |
| STAA | Director | 4,424 | $28.37 | $125.5K | -$6.86M | 15 | 2025-06-20 |
| BTX | Director | 75,000 | $9.03 | $677.2K | $0 | 4 | 2016-10-31 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 14,183 | — | — | $0 | 8 | 2013-05-29 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | — | Grant (A) | +42,507 | $0 | |
| 2025-07-03 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
| 2025-06-20 | STAA | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | — | Grant (A) | +46,512 | $200.0K | |
| 2025-05-13 | STAA | Grant (A) | — | $0 | EDGAR |
| 2025-03-26 | — | Grant (A) | +10,112 | $0 | |
| 2024-07-03 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-27 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2021-08-12 | STAA | Mixed | — | -$4.08M | EDGAR |
| 2021-06-25 | STAA | Exer (M) | +807 | $0 | EDGAR |